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O efeito do ácido S,S-etilenodiaminodi-succínico (edds) na supressão da oxidação do ácido 
ascórbico catalisada por metais (Mn, Fe, Co, Ni, Cu, Zn) foi testado in vitro através da oxidação 
da sonda fluorescente cloreto de 1,2,3-diidrorodamina. A atividade pró-oxidante do ferro não foi 
totalmente suprimida, mesmo sob excesso molar de quatro vezes do ligante. O efeito do meio de 
cultura na toxicidade dos complexos para células mononucleares do sangue periférico (PBMC) e 
da linhagem K562 foi estudado. A citotoxicidade de Fe-edds foi abolida na presença de Trolox ou 
de proteínas do soro. Os prováveis mecanismos de toxicidade celular foram investigados através do 
bloqueio de transportadores de monocarboxilatos (MCT) e estudos de ciclo celular por citometria 
de fluxo. Células tratadas com os complexos metálicos e com o ácido A-ciano-4-hidroxicinâmico,
um conhecido bloqueador de MCT, mostraram recuperação de viabilidade, sugerindo que esses 
transportadores possam estar envolvidos na internalização dos complexos metal-edds. O ácido 
livre promoveu a parada do ciclo celular na fase G0/G1 (PBMC) ou S (K562), sugerindo dano 
direto ao DNA ou interferência na sua duplicação. 
The effect of S,S-ethylenediaminedisuccinic acid (edds) on the quenching of metal-catalyzed 
(metal = Mn, Fe, Co, Ni, Cu, Zn) oxidation of ascorbic acid was tested in vitro via oxidation of 
the fluorescent probe 1,2,3-dihydrorhodamine dihydrochloride. The pro-oxidant activity of iron 
was not fully suppressed, even at a four-fold molar excess of the ligand. The effect of serum on 
the toxicity to peripheral blood mononuclear cells (PBMC) and K562 cells was investigated. The 
cytotoxic effect of Fe-edds was abrogated in the presence of Trolox or serum proteins. The probable 
pathways of cell toxicity were investigated through blocking of the monocarboxylate transporters 
(MCT) in association with cell cycle studies by flow cytometry. Cells treated with metal comple-
xes and A-cyano-4-hydroxycinnamic acid, a known MCT inhibitor, showed recovery of viability, 
suggesting that MCT proteins may be involved in the internalization of metal-edds complexes. 
The free acid induced cell cycle arrest in G0/G1 (PBMC) and S (K562) phases, suggesting direct 
DNA damage or interference in DNA replication.
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Introduction
Ethylenediamminedisuccinic acid (edds) was the first 
natural aminopolycarboxylic acid discovered, isolated from 
a culture of Amycolatopsis orientalis. It was first detected 
due to its ability to inhibit Zn2+-dependent phospholipase 
C activity. Edds has two chiral carbon atoms, resulting in 
three possible stereoisomers [S,S], [R,S] and [R,R].1,2
Technical applications of edds usually involve reme-
diation of soils contaminated with heavy metals, either in 
extraction columns,3 induced in situ phytoextraction4,5 or 
soil washing in permeable barriers.5,6 Comparative tests 
involving [S,S]-edds and edta (ethylenediaminetetraacetic 
acid) were performed to determine their relative efficiencies 
in inducing phytoextraction of heavy metals; [S,S]-edds was 
more efficient for Cu2+ removal, while edta removed Pb2+
preferentially. However, since edds is more biodegradable 
than edta, the former has been recommended as a potential 
replacement for the latter in environmental applications.7,8
The S,S stereoisomer was found to give rise to slightly 
more stable complexes (around 0.3 – 0.5 log units) than the 
R,S isomer, suggesting a small stereospecificity in metal 
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coordination.9 [S,S]-edds is also efficient for radiochemical 
decontamination.10
There are relatively few studies addressing the biologi-
cal activity of this chelator. It is toxic to algae11 and inhibits 
the formation of biofilms by Xylella fastidiosa.12 Its antiviral 
activity in vitro and in vivo, which has been demonstrated 
against cytomegaloviruses, is probably due to inhibition of 
ribonucleotide reductase activity.13
Metal complexes of [S,S]-edds are also highly biode-
gradable,14 but there are no reports of their behavior when 
in biological medium. Their stability is comparable to 
that of edta-containing analogues; therefore, they might 
be involved in altered metal mobilization and availability 
when present in the environment. An understanding of the 
biological activity of metal-edds complexes is important 
both for decontamination applications and for the develop-
ment of metallopharmaceuticals. 
In this paper, we report the biological and pro-oxidant 
activities of several M-[S,S]-edds complexes (M = Fe3+,
Co2+, Ni2+, Zn2+, Cu2+, Mn2+) in K562 and PBMC cells. Also, 
in this study the protective effect of serum proteins against 
toxicity was verified. We found that the oxidant activity 
of iron was not fully inhibited by edds, but Fe-edds cell 
toxicity was halted by the presence of serum and Trolox, 
which acted as antioxidants. In the absence of medium, 
blocking of membrane monocarboxylate transporters 
decreased K562 mortality caused by Fe- and Co-edds 
complexes, which implies that this transport route may be 
used for the internalization of these complexes. Free edds 
induced cell cycle arrest in G0/G1 (PBMC) and S (K562) 
phases, indicating DNA damage or interference with DNA 
replication.
Experimental
Abbreviations: edds, S,S-ethylenediamminedisuccinic 
acid; PBMC, Peripheral Blood Mononuclear Cells; 4-HCA, 
A-cyano-4-hydroxycinnamic acid.
Reagents
The following reagents were used without further 
purification: MnSO
4
H
2
O, FeSO
4
7H
2
O, CuSO
4
5H
2
O, 
NiSO
4
6H
2
O, ZnSO
4
7H
2
O, CoSO
4
7H
2
O, edta disodium 
salt, nitrilotriacetic acid (nta), L-ascorbic acid, NaCl 
(Cromoline, Diadema, Brazil); Octaquest  E30 ([S,S]-edds 
trisodium salt; The Associated Octel Co., UK); Trolox, 
Chelex ,A-cyano-4-hydroxycinnamic acid (4-HCA; Sigma-
Aldrich, St. Louis, MO); N-2-hydroxyethylpiperazine-N’-
2-ethanesulfonic acid (HEPES; Vetec, Rio de Janeiro, 
Brazil); 1,2,3-dihydrorhodamine dihydrochloride (DHR; 
Biotium, Hayward, CA). Ascorbic acid and DHR were 
prepared as concentrated stocks of 8 mmol L-1 in water 
or 50 mmol L-1 in dimethyl sulfoxide, respectively, kept 
frozen as aliquots and thawed immediately before use. 
HEPES-Buffered Saline (HBS) was prepared with 20 mmol 
L-1 HEPES, 150 mmol L-1 NaCl, pH 7.4. Phosphate Buffer 
Saline (PBS) was prepared with 0.14 mol L-1 NaCl; 2.6 
mmol L-1 NaH
2
PO
4
H
2
O and 7.4 mmol L-1 Na
2
HPO
4
7H
2
O, 
pH 7.4. When required, metal-free HBS was prepared by 
treating the solution with Chelex  resin (10 mg mL-1).
Instruments
Spectra were recorded using a Shimadzu UV-1650PC 
(UV-Visible) or a Bomem MB-100 spectrophotometer in 
KBr pellets (infrared). Fluorescence measurements were 
performed in a Tecan GENios microplate reader (Tecan, 
Austria; L
exc
= 485 nm; L
em
= 535 nm) in 96-well microplates 
(TPP, Switzerland). Flow cytometry measurements were 
carried out using a FACS Calibur (Becton Dickinson, CA) 
with laser excitation at 488 nm.
Complexes
M-edds (M = Mn2+, Fe2+, Co2+, Ni2+, Cu2+ or Zn2+) com-
plexes were prepared once a week through the dissolution 
of the appropriate mass of metal salt in a 0.5 mol L-1 edds 
aqueous solution to give a 1:1 metal:edds final stoichiom-
etry. Stock solutions were not kept for longer than one week 
due to the development of mold.
Pro-oxidant activity
The ability of edds to prevent the metal-catalyzed oxida-
tion of ascorbic acid was assessed by a slight modification 
of a previously reported method.15 Metal-nta stock solutions 
were prepared by mixing 100 mmol L-1 nta (titrated to pH 
7.0 with NaOH) with the appropriate mass of metal salt to 
produce a metal:nta molar ratio of 1:10. The objective of 
this procedure was to prevent metal hydrolysis by protect-
ing the metal ion in a well-defined chelate. The nitrilotria-
cetic acid was chosen as the protective ligand because the 
formation constants of its metal complexes are lower than 
those of metal-edds analogues,16 and thus the metal can be 
transferred to edds in the reaction medium. 
The metal-nta solutions were further diluted in water to 
give a final metal concentration of 5 Mmol L-1. 20 ML ali-
quots of these solutions were then transferred, in duplicate, 
to a microplate and mixed with 20 ML aliquots of different 
edds solutions ([edds]
final
 = 0, 2.5, 5, 10 or 20 Mmol L-1). The 
mixtures were then immediately mixed with to 180 ML of 
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a fluorogenic solution consisting of 40 Mmol L-1 ascorbic 
acid and 50 Mmol L-1 DHR in metal-free HBS. Fluorescence 
reading was performed at 37ºC for 40 minutes.
Cell studies
In vitro studies were performed using K562 hu-
man leukemia cells cultured in complete RPMI-1640 
medium (RPMI, 2% glutamax, 40 mg L-1 gentamicine, 
10% heat-inactivated fetal calf serum) at 37 °C and 5% 
CO
2
. Cell viability was determined through Trypan Blue 
counting. Peripheral blood mononuclear cells (PBMC) 
were obtained from healthy donors by centrifugation in a 
Ficoll-Paque™PLUS gradient (GE Biosciences). Briefly, 
blood samples were diluted 1:1 with PBS and layered over 
Ficoll-Paque™PLUS. After centrifugation at 900rg for 30 
minutes at 20 nC, PBMC were harvested at the interface, 
washed in PBS and immediately processed.
To assess the toxicity of the metal-edds complexes and 
the effect of serum proteins, triplicates of 1.0 mL of a cell 
suspension in either complete RPMI medium or PBS (ca.
106 cells mL-1) were transferred into a 24-well plate and 
treated with M-edds solutions at final concentrations of 0, 
10, 100 and 1000 Mmol L-1 of M-edds. After 24 hours of 
incubation, cells were centrifuged at 500rg for 3 minutes 
and resuspended in 50% Trypan Blue in PBS. Live and 
dead cells were counted.
The inhibition of cell monocarboxylate transporters 
(MCT) was assessed in a similar setup, except that cells 
were kept in PBS and treated with 10 mmol L-1 4-HCA 
for 24 h before the addition of 100 Mmol L-1 M-edds com-
plexes (M = Fe, Ni, Co). Controls with no 4-HCA were 
kept under the same conditions. To assess the role of pro-
oxidant activity in cell viability, cells were kept in PBS 
and treated with 100 Mmol L-1 of the antioxidant Trolox 
immediately before the addition of Fe-edds (final concen-
trations: 100 and 1000 Mmol L-1). Controls had no Trolox 
added. Analysis of variance (ANOVA, p < 0.05) followed 
by group comparison using Fisher’s LSD test (Protected 
t-Test) were performed with GB-STAT® software (version 
9.0; Dynamic Microsystems).
For the flow cytometry experiments, the cells (1.0 mL 
aliquots; 1.0r106 mL-1) were incubated in complete RPMI 
for 1 h at 37 ºC and 5% CO
2
 in the presence of 10 Mmol L-1
M-edds or edds alone. Cells were then centrifuged and stained 
with propidium iodide (PI) in hypotonic fluorochrome solution 
(50 Mg mL-1 PI in 0.1% sodium citrate, 0.1% Triton X-100) 
and PI fluorescence was measured by flow cytometry (FACS 
Calibur, Becton Dickinson, San Jose, CA). Data were acquired 
using CellQuest (BD, CA) and analyzed with FlowJo (TreeStar, 
CA) software. The percentage distribution of the cell population 
among the different phases of the cell cycle was calculated using 
the Watson Pragmatic method (G2 defined as 2rG1). 
Results and Discussion
Complexes
The spectroscopic data indicated that edds forms stable, 
hexadentate complexes with most transition metals. The 
infrared analysis of the crystals obtained by recrystalliza-
tion (Table 1) showed the characteristic displacement of 
the asymmetric carboxylate stretching to lower frequencies 
for the complexes, as previously established,17,18 implying 
that this group is involved in the coordination to the metal. 
UV-visible measurements of aqueous solutions of 
[M(H
2
O)
6
]2+ and M-edds (M = Co, Ni, Cu; [M] = [edds] = 
5 Mmol L-1) were also consistent with the formation of 
complexes, with the displacement of the absorption maxima 
(L
abs
) to 492 nm (Co-edds19), 369 and 583 nm (Ni-edds20)
and 670 nm (Cu-edds21). Upon oxidation to FeIII during 
complex formation, Fe-edds solutions turn yellowish-
brown and display a small shoulder at ca. 490 nm.
Pro-oxidant activity
The DHR probe (non-fluorescent in its reduced form) 
undergoes unspecific oxidation and develops fluorescence 
Table 1. Main infrared absorptions (cm-1) for metal-edds complexes
Complex
Literature18 Present study
N(C-O)as N(C-O)s N(C-N) N(C-O)as N(C-O)s N(C-N)
MnII-edds 1630, 1590 1400 1060, 1030 1630 1394 1032
FeIII-edds 1635 1400 1080, 1060 1635 1391 1060, 1106
CoII-edds - - - 1609 1395 1061, 1107
NiII-edds 1680, 1570 1410 1115, 1085 1603 1403 1056, 1112
CuII-edds 1610 1400 1115, 1090 1608 1396 1063, 1108
ZnII-edds 1630, 1595 1400 1060, 1035 1605 1400 -
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in an oxidant concentration-dependent manner. In our 
experimental setting, the slope of a kinetic fluorescence 
curve is directly dependent on the amount of free radicals 
produced during the metal-catalyzed oxidation of ascorbic 
acid in the reaction media. Metal ions, such as Fe3+ and
Cu2+, are known to catalyze this reaction22,23 when in their 
free form, but a plethora of chelators might decrease their 
activity provided that they can bind to the metal through 
available coordination sites.24 Thus, we aimed to verify 
whether edds might behave as an antioxidant in this metal-
promoted oxidation by removing the metal through the 
formation of a stable chelate.
We observed that, except for Fe, all tested metals be-
haved similarly to the control with respect to the decrease 
in the rate of ascorbate oxidation versus [edds] (Figure 1). 
Traces of iron present in the buffer may be responsible 
for the apparent “redox activity” of water alone, which 
subsided with increasing [edds]. However, this should 
not exclude the occurrence of important redox reactions 
promoted by other cations, since the experimental setting 
was optimized for clinical evaluation of redox-active iron.15
As expected, the Zn-edds complex did not show any redox 
activity.
“Free” iron displays high redox activity (Figure 1). 
Interestingly, iron-catalyzed ascorbate oxidation was not 
totally suppressed, even at a four-fold molar excess of edds. 
Two important conclusions might be drawn from this ob-
servation. First, edds is not an antioxidant per se. Second, 
iron chelates such as Fe-edta, which present at least one 
free coordination site, are known to promote the formation 
of reactive oxygen species.24 Indeed, Fe-edta is an excellent 
catalyst of ascorbate oxidation.25 Our observations indicate 
that this is also the case for Fe-edds, since Fe3+ tends to 
form less stable bonds with relatively soft bases like the N 
atoms of edds, which implies that these groups are read-
ily replaced by solvent molecules, the metal remaining 
redox-active. On the other hand, Kovaleva et al.18 identified 
a peak at 1725 cm-1 attributed to the N(C=O)
as
 of a free car-
boxylic group in Fe-edds. They suggested that the nitrogen 
atoms, three oxygen atoms from the carboxyl groups and 
one water molecule form the coordination sphere of Fe3+
in Fe-edds. We did not identify this particular stretching 
frequency in our experiments (Table 1). Kovaleva’s model 
also explains the persistence of available positions (the 
water molecule) through which ascorbate could interact 
with Fe and initiate a cascade of oxidation. It should be 
noted that complete blocking of all available coordination 
sites, in order to prevent unwanted redox side-reactions in
vivo, is one of the requisites for molecules employed in 
iron chelation therapy.15
Cell studies
Initially, we compared the effect of the incubation time 
of M-edds complexes on K562 and PBMC viability (Figure 
2). The tumor line was less resistant to the toxic effects of 
some of the complexes (Fe-edds, Co-edds and Ni-edds) 
after 24 h when compared to PBMC. In fact, virtually no 
toxic effects were observed for non-tumoral ex-vivo cells 
even at high M-edds concentrations and prolonged expo-
sure. Edds is known to capture Zn2+ in biological media,2
therefore it can compete with enzymes for this metal and 
induce loss of enzymatic functions. Curiously, free edds did 
Figure 1.Mmol L-1. Asterisks indicate significant differences from the 
control (water) according to analysis of variance (ANOVA, p < 0.05) 
and comparison of the groups using Fisher’s LSD test (Protected t-Test). 
(b) Example of a typical fluorescence kinetic curve. The figure depicts 
fluorescence intensity (in arbitrary units) versus time for Fe (5 Mmol 
L-1) in the presence of different concentrations of edds. The slopes were 
calculated from t = 15 min onwards.
127Costa et al.Vol. 19, No. 1, 2008
not show high toxicity to the cells (Figure 2), indicating that 
the toxicity of M-edds complexes, when present, depends 
mainly on the nature of the metal being transported into the 
cell. Iron, cobalt and nickel complexes were the most toxic 
to K562 cells, albeit at the relatively high concentrations of 
100 and 1000 Mmol L-1. This observation supports previous 
claims that edds is a useful chelator to reduce metal con-
tamination risks,1 but at the same time indicates that some 
of the M-edds complexes could be effective metallodrugs 
for tumor chemotherapy. 
Since the toxicity of metallodrugs in vivo is critically 
determined by the outcome of their interactions with plasma 
proteins,26 and serum deprivation may stress cells leading 
to higher susceptibility to toxicants and apoptosis, we 
conducted a set of experiments to assess the toxicity of 
M-edds complexes to K562 in the presence and absence 
of serum (Figure 3). 
As anticipated, all control groups displayed higher 
mortality when treated with PBS only (compare right up-
per panel of Figure 2 with Figure 3). Also, Zn-edds was 
more toxic under this condition than in the presence of the 
culture medium. Interestingly, Fe-edds displayed a greatly 
increased rate of mortality in the absence of serum. Pro-
teins such as albumin have extensive antioxidative effects 
in vivo, and we previously noted (Figure 1) that Fe-edds is 
Figure 2. Cytotoxicity of M-edds complexes to K562 and PBMC cells after 1 and 24 h incubation (mean ± S.D.) in complete RPMI medium. Asterisks 
indicate significant differences from the control according to analysis of variance (ANOVA, p < 0.05) and comparison of the groups using Fisher’s LSD 
test (Protected t-Test). The Trypan Blue exclusion test was used to evaluate cell viability.
Figure 3. Cytotoxicity of M-edds complexes to K562 cells after 24 h 
incubation in PBS (mean ± S.D.). Asterisks indicate significant differences 
from the control according to analysis of variance (ANOVA, p < 0.05) and 
comparison of the groups using Fisher’s LSD test (Protected t-Test). The 
Trypan Blue exclusion test was used to evaluate cell viability.
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octanol-water partition (data not shown). A previous report 
accounted for the facilitated transport of aluminum citrate 
by MCT1, suggesting that the transporter would recognize 
a free citrate carboxylate.33 However, it should be noted 
that potential metal ligands, such as acetoacetate, which 
lack this free carboxylic acid motif, are recognized MCT 
substrates.32 To our knowledge, the present work is the first 
report of complexes lacking a free carboxylic function in 
the chelating agent being transported by MCTs. 
The mechanisms by which metal ions cause cell cycle 
arrest are not fully understood, since cell cycle regulation 
is a complex process with several steps, which is prone to 
interference by contaminants. Induction of apoptosis in 
tumor cells is an important strategy for the development 
of improved platinum-based metallodrugs. However, the 
biological response to these drugs seems to be dependent 
on both the cell line and the metal complex structure.34
For instance, vanadium compounds have been shown to 
induce both apoptosis and S phase arrest35 depending on 
the experimental model. Exogenous chelators also interfere 
with the cell cycle, the best known examples coming from 
studies of siderophores employed in iron chelation therapy, 
which may exert useful antitumoral effects by deactivating 
the metalloenzyme ribonucleotide reductase and inducing 
G1/S arrest.36
As with the previous results (Figure 2), we observed 
that cell mortality (apoptosis) was higher for K562 cells 
irrespective of the treatment (Figure 6 and Electronic 
Supplementary Information), which indicates that at least 
some tumor cell lines are less capable than normal cells of 
coping with the stress presented by the metal complexes. 
an effective pro-oxidant of ascorbate (and, presumably, of 
other biological substrates). Therefore, we hypothesized 
that the observed decreased viability of cells treated with 
Fe-edds in PBS might be the result of an oxidative aggres-
sion towards the cells, as observed by other researchers for 
other iron complexes.27,28 To test this point, we conducted a 
comparative study on the viability of cells challenged with 
Fe-edds, using cells which had been treated or not treated 
with the antioxidant Trolox in the absence of serum (Figure 
4). The presence of the antioxidant suppressed toxicity even 
at the highest concentrations of Fe-edds.
To gain some insight into the mechanisms of biologi-
cal action, the cell toxicity studies in the absence of serum 
were repeated in the presence and absence of 4-HCA, a 
known inhibitor of membrane monocarboxylate transporter 
(MCT) proteins.29-31 This family of proteins is involved in 
the transport of short chain carboxylates (pyruvate, lactate), 
ketone bodies and hormones through several biological 
interfaces.32 This test was not performed with cells grown in 
complete RPMI due to the fact that, as previously observed, 
cell toxicity in this case was difficult to observe.
We observed (Figure 5) that 4-HCA-treated cells re-
sisted Fe- and Co-edds toxicity. Ni-edds did not show a 
similar recovery, probably because the concentration was 
too high to verify the role of MCT blocking. This indicates 
that membrane monocarboxylate transporters may be 
required for the internalization of these metal complexes. 
Our results do not rule out other internalization routes 
such as passive diffusion. However, for the anionic M-edds 
complexes, passive diffusion through cell membranes is 
unlikely, since none of these complexes showed a detectable 
Figure 4. Effect of 100 Mmol L-1 Trolox on K562 cell viability after treat-
ment with 100 Mmol L-1 and 1000 Mmol L-1 (mean ± S.D.) of Fe-edds in 
PBS. Asterisks indicate significant differences from the control according 
to analysis of variance (ANOVA, p < 0.05) and comparison of the groups 
using Fisher’s LSD test (Protected t-Test). The Trypan Blue exclusion test 
was used to evaluate cell viability.
Figure 5. Increase of K562 mortality in relation to controls promoted by 
100 Mmol L-1 M-edds (M= Fe, Co, Ni) in the presence or absence of 10 
mmol L-1 4-HCA (mean ± S.D.) in PBS. Asterisks indicate significant 
differences from the control according to analysis of variance (ANOVA, 
p < 0.05) and comparison of the groups using Fisher’s LSD test (Pro-
tected t-Test). The Trypan Blue exclusion test was used to evaluate cell 
viability.
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Figure 6. Cell cycle arrest induced by different M-edds complexes of 
K562 and PBMC cells after 1h treatments (mean ± S.D.) in complete 
RPMI medium. C = control; L = edds ; [edds] = [M-edds] = 10 Mmol L-1.
Asterisks indicate significant differences from the control according to 
analysis of variance (ANOVA, p < 0.05) and comparison of the groups 
using Fisher’s LSD test (Protected t-Test).
In both K562 and PBMC, the free acid edds induced a 
significant phase-specific arrest (G0/G1 in PBMC and 
S in K562). K562 cells treated with Mn-edds showed a 
decreased population in the G2 phase as compared to the 
control, which may be due to the slightly increased number 
of dead cells and/or cells in other phases.
Leukemic cell lines such as K562 are susceptible 
to a number of inducers of apoptosis, and a fraction of 
terminally differentiated cells undergo apoptosis during 
maturation as well.37 Our data corroborate these findings, 
in the sense that K562 cells were more sensitive to M-edds 
toxicity than PBMC cells in all cases.
The G1 checkpoint controls the progression through 
the cell cycle by checking for cell size, presence of growth 
factors, presence of nutrients and DNA damage. Progres-
sion to the S phase occurs after proteins of the Rb family 
are phosphorylated and unbound from E2F transcription 
factors in the DNA molecule. Cells with damaged DNA 
are prevented from progressing to the S phase by the p53 
protein which, among other roles, blocks Rb phosphory-
lation.38 Our results suggest that edds alone, and possibly 
Mn-edds, might either induce direct DNA damage or block 
p53 activity in K562 leukemic cells. Further experiments, 
e.g. an evaluation of nucleotide excision fragments or im-
paired expression of the p53 protein, and the role of edds 
in relation to zinc-finger transcription factors, should be 
performed in order to uncover the precise mechanism of 
action of these metal complexes.
Conclusions
Biodegradable ethylenediamminedisuccinic acid (edds) 
has been proposed as an environmentally friendly alterna-
tive to persistent edta for heavy metal remediation and 
decontamination. The biological activities studied here 
suggest that this acid is not toxic per se to human cells, 
and the toxicity of M-edds complexes is dependent upon 
the nature of M. The toxicity of Fe-edds may, in part, be 
due to its ability to induce redox reactions, although other 
models of oxidative damage (lipid peroxidation, DNA 
damage) should be investigated. Monocarboxylate trans-
porters may be involved in the internalization of M-edds 
complexes. In our study, M-edds complexes also displayed 
some anti-proliferative activity, which should be explored 
further for the development of new metallodrugs for cancer 
chemotherapy.
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Biological Activity of Metal-edds (ethylenediaminedisuccinate) 
Complexes in K562 and PBMC Cells
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Figure S1. K562, 1h – Cell cycle arrest induced by different M-edds complexes on K562 cells after 1-h treatments (mean ± S.D.) in complete RPMI 
medium. L = edds ; [edds] = [M-edds] =  1 - 1000  µmol L-1. Asterisks indicate significant differences from the control according to analysis of variance 
(ANOVA, p < 0.05) and comparison of the groups using Fisher’s LSD test (Protected t-Test).
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Figure S2. PBMC, 1h – Cell cycle arrest induced by different M-edds complexes on PBMC cells after 1-h treatments (mean ± S.D.) in complete RPMI 
medium. L = edds ; [edds] = [M-edds] = 1 - 1000  µmol L-1. Asterisks indicate significant differences from the control according to analysis of variance 
(ANOVA, p < 0.05) and comparison of the groups using Fisher’s LSD test (Protected t-Test).
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